£500K
The funding will support the implementation of specialised screening technology aimed at identifying rare diseases earlier in the patient journey.
M
Mendelian
Mendelian builds screening systems to help doctors identify rare and hard to diagnose conditions.
London, UK—Founded 2015
£500KTotal raised
Mendelian is a healthtech startup based in London that builds screening systems to help clinicians identify patients with rare or hard to diagnose conditions. Its technology analyses medical records to flag potential cases early in the patient journey.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from Mendelian's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Peter Fish
Head of Clinical Partnerships
Peter serves as chief executive of Mendelian, following earlier roles as a co-founder of Tuune and CopperTable. He also advises the Wellcome Sanger Institute.
LinkedInInvestors
